Literature DB >> 12230294

Prevalence of mild impairment in renal function in a random sample of elders from a biethnic community survey.

R D Lindeman1, L J Romero, C L Yau, R N Baumgartner, P J Garry.   

Abstract

The purpose of this study was to compare the prevalences of renal impairment, notably an elevation in serum urea nitrogen and/or serum creatinine concentration, in a randomly selected, biethnic population of Hispanic and non-Hispanic white men and women, and to determine the associations with coronary heart disease and its risk factors (diabetes, hypertension, and dyslipidemia). A survey of health and health-related issues was conducted on 883 volunteers, mean age 74.1 years, randomly selected from the Medicare rolls of Bernalillo County (Albuquerque), New Mexico. Equal numbers of Hispanic and non-Hispanic white men and women were selected and recruited. A fasting serum creatinine and serum urea nitrogen was included in the battery of laboratory tests. Mild elevations of SUN and serum creatinine concentrations are common (9.2%) in an aging, randomly selected population (mean age 74.1 years). Males were more commonly affected than females. There were no differences between Hispanics and non-Hispanic whites, even though diabetes was twice as prevalent in Hispanics. Mild elevations of SUN and serum creatinine were more common in participants with coronary heart disease and its risk factors (diabetes, hypertension, and dyslipidemia). All participants with mild renal impairment had either increased total cholesterol or decreased HDL-cholesterol. One cannot determine from a cross-sectional study whether the dyslipidemia consistently associated with mild renal impairment was a cause of the renal impairment or a result of the renal impairment; however, biological explanations do exist to explain how the dyslipidemias can lead to progressive glomerulosclerosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12230294     DOI: 10.1023/a:1019590416234

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  17 in total

Review 1.  Nephropathy in patients with type 2 diabetes mellitus.

Authors:  E Ritz; S R Orth
Journal:  N Engl J Med       Date:  1999-10-07       Impact factor: 91.245

2.  Prevalences of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly, biethnic population.

Authors:  R D Lindeman; L J Romero; R Hundley; A S Allen; H C Liang; R N Baumgartner; K M Koehler; D S Schade; P J Garry
Journal:  Diabetes Care       Date:  1998-06       Impact factor: 19.112

3.  Ischemic heart disease mortality in Hispanics, American Indians, and non-Hispanic whites in New Mexico, 1958-1982.

Authors:  T M Becker; C Wiggins; C R Key; J M Samet
Journal:  Circulation       Date:  1988-08       Impact factor: 29.690

4.  Effects of hypertension and dyslipidemia on the decline in renal function.

Authors:  M Mänttäri; E Tiula; T Alikoski; V Manninen
Journal:  Hypertension       Date:  1995-10       Impact factor: 10.190

Review 5.  The role of lipids in nephrosclerosis and glomerulosclerosis.

Authors:  E F Gröne; A K Walli; H J Gröne; B Miller; D Seidel
Journal:  Atherosclerosis       Date:  1994-05       Impact factor: 5.162

6.  Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?

Authors:  J C Whittle; P K Whelton; A J Seidler; M J Klag
Journal:  Arch Intern Med       Date:  1991-07

Review 7.  Hyperlipidemia and progressive renal disease.

Authors:  W F Keane; W S Mulcahy; B L Kasiske; Y Kim; M P O'Donnell
Journal:  Kidney Int Suppl       Date:  1991-04       Impact factor: 10.545

Review 8.  Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease.

Authors:  P O Attman; P Alaupovic; O Samuelsson
Journal:  Kidney Int Suppl       Date:  1999-07       Impact factor: 10.545

9.  Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey.

Authors:  C A Jones; G M McQuillan; J W Kusek; M S Eberhardt; W H Herman; J Coresh; M Salive; C P Jones; L Y Agodoa
Journal:  Am J Kidney Dis       Date:  1998-12       Impact factor: 8.860

Review 10.  Lipid abnormalities and changes in plasma proteins in glomerular diseases and chronic renal failure.

Authors:  C Guijarro; W F Keane
Journal:  Curr Opin Nephrol Hypertens       Date:  1993-05       Impact factor: 2.894

View more
  2 in total

Review 1.  The aging kidney: a review--part II.

Authors:  Fred G Silva
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Impact of comorbidities and drug therapy on development of renal impairment in a predominantly African American and Hispanic HIV clinic population.

Authors:  M Keith Rawlings; Jennifer Klein; Edna P Toubes Klingler; Ejeanée Queen; Lauren Rogers; Linda H Yau; Keith A Pappa; Gary E Pakes
Journal:  HIV AIDS (Auckl)       Date:  2011-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.